Skip to main content

Advertisement

Table 2 The relationship between response frequency of HPV E1-specific T cell response in peripheral blood and clinical features in patients with cervical squamous cell carcinoma

From: Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma

Factor N Frequency (%) χ 2 P-value
Age
(year)
≤54 32 53.13 0.915 0.339
> 54 34 64.71
Family history of cancer No 59 57.63 0.678 0.767
Yes 7 71.43
History of miscarriage No 30 56.67 0.134 0.715
Yes 36 61.11
Tumor size
(cm)
≤5 43 58.14 0.046 0.830
> 5 23 60.87
Tumor type Cauliflower 25 52.00 1.868 0.60
Nodular 29 58.62
Hollow 7 71.43
Others 5 80.00
Histologic grade Well 2 0 4.465 0.215
Moderate 45 64.44
Poor 13 53.85
Papillary 6 50.00
FIGO stage IIB 34 59.38 0.002 0.964
IIIA-IIIB 32 58.82
SCC-Ag Normal 12 75.00 1.536 0.215
Anormal 54 55.56
CEA Normal 42 64.29 1.289 0.256
Anormal 24 50.00
TSGF Normal 46 54.35 1.413 0.235
Anormal 20 70.00
Pelvic lymph nodes No 37 64.86 1.161 0.281
Yes 29 51.72
  1. N number of patients, FIGO International Federation of Gynecology and Obstetrics, SCC-Ag Squamous cell carcinoma antigen, CEA carcinoembryonic antigen, TSGF Tumor specific growth factor